True Wealth Design’s Relay Therapeutics RLAY Stock Holding History

True Wealth Design’s Portfolio RLAY Stock Details RLAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$4.82K	Hold	267	–	–	﹤0.01%	1356
2026 Q2	$5K	Sell	267 -11	-4%	-$160	﹤0.01%	1328
2026 Q1	$2.77K	Hold	278	–	–	﹤0.01%	1413
2025 Q4	$2.35K	Hold	278	–	–	﹤0.01%	1393
2025 Q3	$1.45K	Buy	278 +163	+142%	+$622	﹤0.01%	1609
2025 Q2	$398	Buy	115 +36	+46%	+$107	﹤0.01%	1833
2025 Q1	$207	Buy	79 +11	+16%	+$43	﹤0.01%	1937
2024 Q4	$281	Buy	+68	New	+$370	﹤0.01%	1175

Other funds holding RLAY

TGY2IT

Timothy G. Youngquist 2020 Irrevocable Trust Fort Myers, Florida $530M AUM 95.29% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

VFA

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.15% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

FFO

Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return

VCM

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

MPWT

MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

True Wealth Design's RLAY Position: Q3 2026 in Review

True Wealth Design held its Relay Therapeutics (RLAY) position steady in Q3 2026 at 267 shares worth $4.82K. The position accounts for ﹤0.01% of the portfolio, ranked #1356.

True Wealth Design first reported a position in RLAY in Q4 2024 and has held it in 8 quarters since. The position peaked at $5K in Q2 2026. 11 funds tracked by Wall St. Rank hold RLAY as of Q3 2026.

True Wealth Design held 267 shares of Relay Therapeutics worth $4.82K as of Q3 2026.
True Wealth Design left its Relay Therapeutics share count unchanged in Q3 2026.
Relay Therapeutics made up ﹤0.01% of True Wealth Design's portfolio in Q3 2026, its #1356 holding.
True Wealth Design first reported a position in Relay Therapeutics in Q4 2024 and has held it in 8 quarters since.
True Wealth Design's Relay Therapeutics position peaked at $5K in Q2 2026.
11 funds tracked by Wall St. Rank held Relay Therapeutics as of Q3 2026.

Based on True Wealth Design's 13F filing for Q3 2026, filed 13 Oct 2026.